{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:26:02Z","timestamp":1777400762809,"version":"3.51.4"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,5]]},"DOI":"10.7759\/cureus.73058","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T14:24:22Z","timestamp":1730816662000},"source":"Crossref","is-referenced-by-count":1,"title":["Kratom: A Narrative Review of the Possible Clinical Uses and Dangers of This Opioid-Like Plant"],"prefix":"10.7759","author":[{"given":"Amber  N","family":"Edinoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah  E","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor  C","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William  C","family":"Upshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elyse M","family":"Cornett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin  S","family":"Murnane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam M","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar","family":"Shekoohi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan D","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s40429-023-00478-3","article-title":"Clinical implications of kratom (Mitragyna speciosa) use: a literature review","volume":"10","author":"Prevete E","year":"2023","unstructured":"Prevete E, Kuypers KP, Theunissen EL, Esposito G, Ramaekers JG, Pasquini M, Corazza O. Clinical implications of kratom (Mitragyna speciosa) use: a literature review. Curr Addict Rep. 2023, 10:317-34. 10.1007\/s40429-023-00478-3","journal-title":"Curr Addict Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2017.03.020","article-title":"A botanical, phytochemical and ethnomedicinal review of the genus Mitragyna korth: Implications for products sold as kratom","volume":"202","author":"Brown PN","year":"2017","unstructured":"Brown PN, Lund JA, Murch SJ. A botanical, phytochemical and ethnomedicinal review of the genus Mitragyna korth: Implications for products sold as kratom. J Ethnopharmacol. 2017, 202:302-25. 10.1016\/j.jep.2017.03.020","journal-title":"J Ethnopharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00414-015-1279-y","article-title":"The pharmacology and toxicology of kratom: from traditional herb to drug of abuse","volume":"130","author":"Warner ML","year":"2016","unstructured":"Warner ML, Kaufman NC, Grundmann O. The pharmacology and toxicology of kratom: from traditional herb to drug of abuse. Int J Legal Med. 2016, 130:127-38. 10.1007\/s00414-015-1279-y","journal-title":"Int J Legal Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-011-0202-2","article-title":"Here today, gone tomorrow\u2026and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines","volume":"8","author":"Rosenbaum CD","year":"2012","unstructured":"Rosenbaum CD, Carreiro SP, Babu KM. Here today, gone tomorrow\u2026and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. J Med Toxicol. 2012, 8:15-32. 10.1007\/s13181-011-0202-2","journal-title":"J Med Toxicol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2012.11.012","article-title":"From Kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction","volume":"37","author":"Hassan Z","year":"2013","unstructured":"Hassan Z, Muzaimi M, Navaratnam V, et al.. From Kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction. Neurosci Biobehav Rev. 2013, 37:138-51. 10.1016\/j.neubiorev.2012.11.012","journal-title":"Neurosci Biobehav Rev"},{"key":"ref6","article-title":"Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects","volume":"112","author":"Prozialeck WC","year":"2012","unstructured":"Prozialeck WC, Jivan JK, Andurkar SV. Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects. J Am Osteopath Assoc. 2012, 112:792-9.","journal-title":"J Am Osteopath Assoc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/968786","article-title":"Following \"the roots\" of kratom (Mitragyna speciosa): the evolution of an enhancer from a traditional use to increase work and productivity in southeast asia to a recreational psychoactive drug in western countries","volume":"2015","author":"Cinosi E","year":"2015","unstructured":"Cinosi E, Martinotti G, Simonato P, et al.. Following \"the roots\" of kratom (Mitragyna speciosa): the evolution of an enhancer from a traditional use to increase work and productivity in southeast asia to a recreational psychoactive drug in western countries. Biomed Res Int. 2015, 2015:968786. 10.1155\/2015\/968786","journal-title":"Biomed Res Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2021.07.021","article-title":"Kratom use is underestimated, but prevalence still appears to be low","volume":"62","author":"Palamar JJ","year":"2022","unstructured":"Palamar JJ. Kratom use is underestimated, but prevalence still appears to be low. Am J Prev Med. 2022, 62:133-4. 10.1016\/j.amepre.2021.07.021","journal-title":"Am J Prev Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2013.844532","article-title":"Kratom abuse in Ramathibodi Poison Center, Thailand: a five-year experience","volume":"45","author":"Trakulsrichai S","year":"2013","unstructured":"Trakulsrichai S, Tongpo A, Sriapha C, Wongvisawakorn S, Rittilert P, Kaojarern S, Wananukul W. Kratom abuse in Ramathibodi Poison Center, Thailand: a five-year experience. J Psychoactive Drugs. 2013, 45:404-8. 10.1080\/02791072.2013.844532","journal-title":"J Psychoactive Drugs"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp161035","article-title":"Pharmacologic and clinical assessment of kratom","volume":"75","author":"White CM","year":"2018","unstructured":"White CM. Pharmacologic and clinical assessment of kratom. Am J Health Syst Pharm. 2018, 75:261-7. 10.2146\/ajhp161035","journal-title":"Am J Health Syst Pharm"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-011-0155-5","article-title":"Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna speciosa)","volume":"7","author":"Kapp FG","year":"2011","unstructured":"Kapp FG, Maurer HH, Auw\u00e4rter V, Winkelmann M, Hermanns-Clausen M. Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna speciosa). J Med Toxicol. 2011, 7:227-31. 10.1007\/s13181-011-0155-5","journal-title":"J Med Toxicol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.03.017","article-title":"Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users","volume":"139","author":"Singh D","year":"2014","unstructured":"Singh D, M\u00fcller CP, Vicknasingam BK. Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users. Drug Alcohol Depend. 2014, 139:132-7. 10.1016\/j.drugalcdep.2014.03.017","journal-title":"Drug Alcohol Depend"},{"key":"ref13","article-title":"Novel case of maternal and neonatal kratom dependence and withdrawal","volume":"64","author":"Mackay L","year":"2018","unstructured":"Mackay L, Abrahams R. Novel case of maternal and neonatal kratom dependence and withdrawal. Can Fam Physician. 2018, 64:121-2.","journal-title":"Can Fam Physician"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1080\/10550490701525368","article-title":"Self-treatment of opioid withdrawal with a dietary supplement, Kratom","volume":"16","author":"Boyer EW","year":"2007","unstructured":"Boyer EW, Babu KM, Macalino GE. Self-treatment of opioid withdrawal with a dietary supplement, Kratom. Am J Addict. 2007, 16:352-6.","journal-title":"Am J Addict"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.03.007","article-title":"Patterns of kratom use and health impact in the US-Results from an online survey","volume":"176","author":"Grundmann O","year":"2017","unstructured":"Grundmann O. Patterns of kratom use and health impact in the US-Results from an online survey. Drug Alcohol Depend. 2017, 176:63-70. 10.1016\/j.drugalcdep.2017.03.007","journal-title":"Drug Alcohol Depend"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.12788\/acp.0012","article-title":"Kratom: a growing substance of abuse in the United States","volume":"32","author":"Demick DS","year":"2020","unstructured":"Demick DS, Lee TT, Summers AT, El-Mallakh RS. Kratom: a growing substance of abuse in the United States. Ann Clin Psychiatry. 2020, 32:275-80. 10.12788\/acp.0012","journal-title":"Ann Clin Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2016.1229876","article-title":"Do you get what you paid for? An examination of products advertised as kratom","volume":"48","author":"Griffin OH 3rd","year":"2016","unstructured":"Griffin OH 3rd, Daniels JA, Gardner EA. Do you get what you paid for? An examination of products advertised as kratom. J Psychoactive Drugs. 2016, 48:330-5. 10.1080\/02791072.2016.1229876","journal-title":"J Psychoactive Drugs"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.789075","article-title":"Kratom use in the US: both a regional phenomenon and a white middle-class phenomenon? Evidence from NSDUH 2019 and an online convenience sample","volume":"12","author":"Rogers JM","year":"2021","unstructured":"Rogers JM, Smith KE, Strickland JC, Epstein DH. Kratom use in the US: both a regional phenomenon and a white middle-class phenomenon? Evidence from NSDUH 2019 and an online convenience sample. Front Pharmacol. 2021, 12:789075. 10.3389\/fphar.2021.789075","journal-title":"Front Pharmacol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2022.107295","article-title":"The association between e-cigarette use and kratom use among US adults","volume":"164","author":"Lee J","year":"2022","unstructured":"Lee J, Terashima JP, Parker MA. The association between e-cigarette use and kratom use among US adults. Prev Med. 2022, 164:107295. 10.1016\/j.ypmed.2022.107295","journal-title":"Prev Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.04.011","article-title":"The rise of e-cigarettes, pod mod devices, and JUUL among youth: factors influencing use, health implications, and downstream effects","volume":"201","author":"Fadus MC","year":"2019","unstructured":"Fadus MC, Smith TT, Squeglia LM. The rise of e-cigarettes, pod mod devices, and JUUL among youth: factors influencing use, health implications, and downstream effects. Drug Alcohol Depend. 2019, 201:85-93. 10.1016\/j.drugalcdep.2019.04.011","journal-title":"Drug Alcohol Depend"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107849","article-title":"Kratom (Mitragyna speciosa): user demographics, use patterns, and implications for the opioid epidemic","volume":"208","author":"Garcia-Romeu A","year":"2020","unstructured":"Garcia-Romeu A, Cox DJ, Smith KE, Dunn KE, Griffiths RR. Kratom (Mitragyna speciosa): user demographics, use patterns, and implications for the opioid epidemic. Drug Alcohol Depend. 2020, 208:107849. 10.1016\/j.drugalcdep.2020.107849","journal-title":"Drug Alcohol Depend"},{"key":"ref22","article-title":"The potential for kratom as an antidepressant and antipsychotic","volume":"93","author":"Johnson LE","year":"2020","unstructured":"Johnson LE, Balyan L, Magdalany A, et al.. The potential for kratom as an antidepressant and antipsychotic. Yale J Biol Med. 2020, 93:283-9.","journal-title":"Yale J Biol Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02209.x","article-title":"Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth)","volume":"103","author":"Boyer EW","year":"2008","unstructured":"Boyer EW, Babu KM, Adkins JE, McCurdy CR, Halpern JH. Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth). Addiction. 2008, 103:1048-50. 10.1111\/j.1360-0443.2008.02209.x","journal-title":"Addiction"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2020.1812627","article-title":"Is kratom (Mitragyna speciosa Korth.) use associated with ECG abnormalities? Electrocardiogram comparisons between regular kratom users and controls","volume":"59","author":"Leong Abdullah MF","year":"2021","unstructured":"Leong Abdullah MF, Tan KL, Narayanan S, et al.. Is kratom (Mitragyna speciosa Korth.) use associated with ECG abnormalities? Electrocardiogram comparisons between regular kratom users and controls. Clin Toxicol (Phila). 2021, 59:400-8. 10.1080\/15563650.2020.1812627","journal-title":"Clin Toxicol (Phila)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2019.1569236","article-title":"Kratom exposures reported to United States poison control centers: 2011-2017","volume":"57","author":"Post S","year":"2019","unstructured":"Post S, Spiller HA, Chounthirath T, Smith GA. Kratom exposures reported to United States poison control centers: 2011-2017. Clin Toxicol (Phila). 2019, 57:847-54. 10.1080\/15563650.2019.1569236","journal-title":"Clin Toxicol (Phila)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.05.005","article-title":"Kratom as a substitute for opioids: results from an online survey","volume":"202","author":"Coe MA","year":"2019","unstructured":"Coe MA, Pillitteri JL, Sembower MA, Gerlach KK, Henningfield JE. Kratom as a substitute for opioids: results from an online survey. Drug Alcohol Depend. 2019, 202:24-32. 10.1016\/j.drugalcdep.2019.05.005","journal-title":"Drug Alcohol Depend"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-019-00741-y","article-title":"Kratom adulterated with phenylethylamine and associated intracerebral hemorrhage: linking toxicologists and public health officials to identify dangerous adulterants","volume":"16","author":"Nacca N","year":"2020","unstructured":"Nacca N, Schult RF, Li L, Spink DC, Ginsberg G, Navarette K, Marraffa J. Kratom adulterated with phenylethylamine and associated intracerebral hemorrhage: linking toxicologists and public health officials to identify dangerous adulterants. J Med Toxicol. 2020, 16:71-4. 10.1007\/s13181-019-00741-y","journal-title":"J Med Toxicol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/PAF.0000000000000695","article-title":"Kratom-associated fatalities in northern nevada-what Mitragynine level is fatal?","volume":"42","author":"Schmitt J","year":"2021","unstructured":"Schmitt J, Bingham K, Knight LD. Kratom-associated fatalities in northern nevada-what Mitragynine level is fatal?. Am J Forensic Med Pathol. 2021, 42:341-9. 10.1097\/PAF.0000000000000695","journal-title":"Am J Forensic Med Pathol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102715","article-title":"The internet market for kratom, an opioid alternative and variably legal recreational drug","volume":"78","author":"Williams RS","year":"2020","unstructured":"Williams RS, Nikitin D. The internet market for kratom, an opioid alternative and variably legal recreational drug. Int J Drug Policy. 2020, 78:102715. 10.1016\/j.drugpo.2020.102715","journal-title":"Int J Drug Policy"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2010.08.011","article-title":"Antidepressant-like effect of mitragynine isolated from Mitragyna speciosa Korth in mice model of depression","volume":"18","author":"Idayu NF","year":"2011","unstructured":"Idayu NF, Hidayat MT, Moklas MA, Sharida F, Raudzah AR, Shamima AR, Apryani E. Antidepressant-like effect of mitragynine isolated from Mitragyna speciosa Korth in mice model of depression. Phytomedicine. 2011, 18:402-7. 10.1016\/j.phymed.2010.08.011","journal-title":"Phytomedicine"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.6b00360","article-title":"Synthetic and receptor signaling explorations of the Mitragyna alkaloids: Mitragynine as an atypical molecular framework for opioid receptor modulators","volume":"138","author":"Kruegel AC","year":"2016","unstructured":"Kruegel AC, Gassaway MM, Kapoor A, et al.. Synthetic and receptor signaling explorations of the Mitragyna alkaloids: Mitragynine as an atypical molecular framework for opioid receptor modulators. J Am Chem Soc. 2016, 138:6754-64. 10.1021\/jacs.6b00360","journal-title":"J Am Chem Soc"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00096","article-title":"Indole alkaloids from plants as potential leads for antidepressant drugs: a mini review","volume":"8","author":"Hamid HA","year":"2017","unstructured":"Hamid HA, Ramli AN, Yusoff MM. Indole alkaloids from plants as potential leads for antidepressant drugs: a mini review. Front Pharmacol. 2017, 8:96. 10.3389\/fphar.2017.00096","journal-title":"Front Pharmacol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00464","article-title":"Mitragyna speciosa leaf extract exhibits antipsychotic-like effect with the potential to alleviate positive and negative symptoms of psychosis in mice","volume":"7","author":"Vijeepallam K","year":"2016","unstructured":"Vijeepallam K, Pandy V, Kunasegaran T, Murugan DD, Naidu M. Mitragyna speciosa leaf extract exhibits antipsychotic-like effect with the potential to alleviate positive and negative symptoms of psychosis in mice. Front Pharmacol. 2016, 7:464. 10.3389\/fphar.2016.00464","journal-title":"Front Pharmacol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2007.01.061","article-title":"Fos-like immunoreactivity in rat dorsal raphe nuclei induced by alkaloid extract of Mitragyna speciosa","volume":"416","author":"Kumarnsit E","year":"2007","unstructured":"Kumarnsit E, Vongvatcharanon U, Keawpradub N, Intasaro P. Fos-like immunoreactivity in rat dorsal raphe nuclei induced by alkaloid extract of Mitragyna speciosa. Neurosci Lett. 2007, 416:128-32. 10.1016\/j.neulet.2007.01.061","journal-title":"Neurosci Lett"},{"key":"ref35","doi-asserted-by":"crossref","DOI":"10.1002\/pds.1276","article-title":"Increasing deaths from opioid analgesics in the United States","volume":"15","author":"Paulozzi LJ","year":"2006","unstructured":"Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf. 2006, 15:618-27.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref36","article-title":"Opioid Addiction","author":"Azadfard M","year":"2023","unstructured":"Azadfard M, Huecker MR, Leaming JM. Opioid Addiction. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00411","article-title":"Mitragynine attenuates morphine withdrawal effects in rats-a comparison with methadone and buprenorphine","volume":"11","author":"Hassan R","year":"2020","unstructured":"Hassan R, Pike See C, Sreenivasan S, Mansor SM, M\u00fcller CP, Hassan Z. Mitragynine attenuates morphine withdrawal effects in rats-a comparison with methadone and buprenorphine. Front Psychiatry. 2020, 11:411. 10.3389\/fpsyt.2020.00411","journal-title":"Front Psychiatry"},{"key":"ref38","article-title":"Abuse potential and adverse cognitive effects of mitragynine (kratom)","volume":"21","author":"Yusoff NHM","year":"2016","unstructured":"Yusoff NHM, Suhaimi FW, Vadivelu RK, et al.. Abuse potential and adverse cognitive effects of mitragynine (kratom). Addict Biol. 2016, 21:98-110.","journal-title":"Addict Biol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2018.1562133","article-title":"Kratom withdrawal: a systematic review with case series","volume":"51","author":"Stanciu CN","year":"2019","unstructured":"Stanciu CN, Gnanasegaram SA, Ahmed S, Penders T. Kratom withdrawal: a systematic review with case series. J Psychoactive Drugs. 2019, 51:12-8. 10.1080\/02791072.2018.1562133","journal-title":"J Psychoactive Drugs"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-020-00151-x","article-title":"Kratom-pharmacology, clinical implications, and outlook: a comprehensive review","volume":"9","author":"Eastlack SC","year":"2020","unstructured":"Eastlack SC, Cornett EM, Kaye AD. Kratom-pharmacology, clinical implications, and outlook: a comprehensive review. Pain Ther. 2020, 9:55-69. 10.1007\/s40122-020-00151-x","journal-title":"Pain Ther"},{"key":"ref41","article-title":"Kratom","author":"Jentsch MJ","year":"2023","unstructured":"Jentsch MJ, Pippin MM. Kratom. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.120.000189","article-title":"Pharmacological comparison of Mitragynine and 7-hydroxymitragynine: In vitro affinity and efficacy for \u03bc-opioid receptor and opioid-like behavioral effects in rats","volume":"376","author":"Obeng S","year":"2021","unstructured":"Obeng S, Wilkerson JL, Le\u00f3n F, et al.. Pharmacological comparison of Mitragynine and 7-hydroxymitragynine: In vitro affinity and efficacy for \u03bc-opioid receptor and opioid-like behavioral effects in rats. J Pharmacol Exp Ther. 2021, 376:410-27. 10.1124\/jpet.120.000189","journal-title":"J Pharmacol Exp Ther"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.805986","article-title":"The chemical and pharmacological properties of Mitragynine and its diastereomers: an insight review","volume":"13","author":"Karunakaran T","year":"2022","unstructured":"Karunakaran T, Ngew KZ, Zailan AA, Mian Jong VY, Abu Bakar MH. The chemical and pharmacological properties of Mitragynine and its diastereomers: an insight review. Front Pharmacol. 2022, 13:805986. 10.3389\/fphar.2022.805986","journal-title":"Front Pharmacol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2003.09.054","article-title":"Antinociceptive effect of 7-hydroxymitragynine in mice: discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa","volume":"74","author":"Matsumoto K","year":"2004","unstructured":"Matsumoto K, Horie S, Ishikawa H, Takayama H, Aimi N, Ponglux D, Watanabe K. Antinociceptive effect of 7-hydroxymitragynine in mice: discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa. Life Sci. 2004, 74:2143-55. 10.1016\/j.lfs.2003.09.054","journal-title":"Life Sci"},{"key":"ref45","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.1c00726","article-title":"Activity of Mitragyna speciosa (\u201ckratom\u201d) alkaloids at serotonin receptors","volume":"64","author":"Le\u00f3n F","year":"2021","unstructured":"Le\u00f3n F, Obeng S, Martinelli M, . Activity of Mitragyna speciosa (\u201ckratom\u201d) alkaloids at serotonin receptors. J Med Chem. 2021, 64:13510-23.","journal-title":"J Med Chem"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.52.916","article-title":"Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa","volume":"52","author":"Takayama H","year":"2004","unstructured":"Takayama H. Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa. Chem Pharm Bull (Tokyo). 2004, 52:916-28. 10.1248\/cpb.52.916","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2020.104558","article-title":"Indole alkaloids: 2012 until now, highlighting the new chemical structures and biological activities","volume":"143","author":"Rosales PF","year":"2020","unstructured":"Rosales PF, Bordin GS, Gower AE, Moura S. Indole alkaloids: 2012 until now, highlighting the new chemical structures and biological activities. Fitoterapia. 2020, 143:104558. 10.1016\/j.fitote.2020.104558","journal-title":"Fitoterapia"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.1c00149","article-title":"Kratom alkaloids as probes for opioid receptor function: pharmacological characterization of minor indole and oxindole alkaloids from kratom","volume":"12","author":"Chakraborty S","year":"2021","unstructured":"Chakraborty S, Uprety R, Daibani AE, et al.. Kratom alkaloids as probes for opioid receptor function: pharmacological characterization of minor indole and oxindole alkaloids from kratom. ACS Chem Neurosci. 2021, 12:2661-78. 10.1021\/acschemneuro.1c00149","journal-title":"ACS Chem Neurosci"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jnatprod.0c01055","article-title":"Exploring the chemistry of alkaloids from malaysian Mitragyna speciosa (Kratom) and the role of oxindoles on human opioid receptors","volume":"84","author":"Chear NJ","year":"2021","unstructured":"Chear NJ, Le\u00f3n F, Sharma A, et al.. Exploring the chemistry of alkaloids from malaysian Mitragyna speciosa (Kratom) and the role of oxindoles on human opioid receptors. J Nat Prod. 2021, 84:1034-43. 10.1021\/acs.jnatprod.0c01055","journal-title":"J Nat Prod"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b00748","article-title":"Mitragynine\/corynantheidine pseudoindoxyls as opioid analgesics with Mu agonism and delta antagonism, which do not recruit \u03b2-Arrestin-2","volume":"59","author":"V\u00e1radi A","year":"2016","unstructured":"V\u00e1radi A, Marrone GF, Palmer TC, et al.. Mitragynine\/corynantheidine pseudoindoxyls as opioid analgesics with Mu agonism and delta antagonism, which do not recruit \u03b2-Arrestin-2. J Med Chem. 2016, 59:8381-97. 10.1021\/acs.jmedchem.6b00748","journal-title":"J Med Chem"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2010.08.003","article-title":"The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics","volume":"60","author":"Raehal KM","year":"2011","unstructured":"Raehal KM, Bohn LM. The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics. Neuropharmacology. 2011, 60:58-65. 10.1016\/j.neuropharm.2010.08.003","journal-title":"Neuropharmacology"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-23-10494.2002","article-title":"Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice","volume":"22","author":"Bohn LM","year":"2002","unstructured":"Bohn LM, Lefkowitz RJ, Caron MG. Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice. J Neurosci. 2002, 22:10494-500. 10.1523\/JNEUROSCI.22-23-10494.2002","journal-title":"J Neurosci"},{"key":"ref53","article-title":"Opioid receptors and legal highs: Salvia divinorum and Kratom","volume":"46","author":"Babu KM","year":"20081","unstructured":"Babu KM, McCurdy CR, Boyer EW. Opioid receptors and legal highs: Salvia divinorum and Kratom. Clin Toxicol. 20081, 46:146-52.","journal-title":"Clin Toxicol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2016.05.004","article-title":"Traditional and non-traditional uses of Mitragynine (kratom): A survey of the literature","volume":"126","author":"Singh D","year":"2016","unstructured":"Singh D, Narayanan S, Vicknasingam B. Traditional and non-traditional uses of Mitragynine (kratom): A survey of the literature. Brain Res Bull. 2016, 126:41-6. 10.1016\/j.brainresbull.2016.05.004","journal-title":"Brain Res Bull"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2011.03.005","article-title":"Metabolism studies of the kratom alkaloids mitraciliatine and isopaynantheine, diastereomers of the main alkaloids mitragynine and paynantheine, in rat and human urine using liquid chromatography-linear ion trap-mass spectrometry","volume":"879","author":"Philipp AA","year":"2011","unstructured":"Philipp AA, Wissenbach DK, Weber AA, Zapp J, Maurer HH. Metabolism studies of the kratom alkaloids mitraciliatine and isopaynantheine, diastereomers of the main alkaloids mitragynine and paynantheine, in rat and human urine using liquid chromatography-linear ion trap-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2011, 879:1049-55. 10.1016\/j.jchromb.2011.03.005","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkz108","article-title":"CYP450-mediated metabolism of Mitragynine and investigation of metabolites in human urine","volume":"44","author":"Basiliere S","year":"2020","unstructured":"Basiliere S, Kerrigan S. CYP450-mediated metabolism of Mitragynine and investigation of metabolites in human urine. J Anal Toxicol. 2020, 44:301-13. 10.1093\/jat\/bkz108","journal-title":"J Anal Toxicol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2018.1552819","article-title":"Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of Mitragyna speciosa (kratom)","volume":"49","author":"Kamble SH","year":"2019","unstructured":"Kamble SH, Sharma A, King TI, Le\u00f3n F, McCurdy CR, Avery BA. Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of Mitragyna speciosa (kratom). Xenobiotica. 2019, 49:1279-88. 10.1080\/00498254.2018.1552819","journal-title":"Xenobiotica"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12661","article-title":"Rate and extent of mitragynine and 7-hydroxymitragynine blood-brain barrier transport and their intra-brain distribution: the missing link in pharmacodynamic studies","volume":"24","author":"Yusof SR","year":"2019","unstructured":"Yusof SR, Mohd Uzid M, Teh EH, et al.. Rate and extent of mitragynine and 7-hydroxymitragynine blood-brain barrier transport and their intra-brain distribution: the missing link in pharmacodynamic studies. Addict Biol. 2019, 24:935-45. 10.1111\/adb.12661","journal-title":"Addict Biol"},{"key":"ref59","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2015.00189","article-title":"Subchronic toxicity study of standardized methanolic extract of Mitragyna speciosa Korth in Sprague-Dawley Rats","volume":"9","author":"Ilmie MU","year":"2015","unstructured":"Ilmie MU, Jaafar H, Mansor SM, Abdullah JM. Subchronic toxicity study of standardized methanolic extract of Mitragyna speciosa Korth in Sprague-Dawley Rats. Front Neurosci. 2015, 9:189.","journal-title":"Front Neurosci"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115648","article-title":"Evaluation of the cardiotoxicity of mitragynine and its analogues using human induced pluripotent stem cell-derived cardiomyocytes","volume":"9","author":"Lu J","year":"2014","unstructured":"Lu J, Wei H, Wu J, et al.. Evaluation of the cardiotoxicity of mitragynine and its analogues using human induced pluripotent stem cell-derived cardiomyocytes. PLoS One. 2014, 9:e115648. 10.1371\/journal.pone.0115648","journal-title":"PLoS One"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3390\/molecules16097344","article-title":"Evaluation of the effects of Mitragyna speciosa alkaloid extract on cytochrome P450 enzymes using a high throughput assay","volume":"16","author":"Kong WM","year":"2011","unstructured":"Kong WM, Chik Z, Ramachandra M, Subramaniam U, Aziddin RE, Mohamed Z. Evaluation of the effects of Mitragyna speciosa alkaloid extract on cytochrome P450 enzymes using a high throughput assay. Molecules. 2011, 16:7344-56. 10.3390\/molecules16097344","journal-title":"Molecules"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2019.11.005","article-title":"Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids","volume":"319","author":"Kamble SH","year":"2020","unstructured":"Kamble SH, Sharma A, King TI, et al.. Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids. Toxicol Lett. 2020, 319:148-54. 10.1016\/j.toxlet.2019.11.005","journal-title":"Toxicol Lett"},{"key":"ref63","article-title":"Inhibition of UGT2B7 enzyme activity in human and rat liver microsomes by herbal constituents","volume":"23","author":"Abdullah NH","year":"2018","unstructured":"Abdullah NH, Ismail S. Inhibition of UGT2B7 enzyme activity in human and rat liver microsomes by herbal constituents. Mol Basel Switz. 2018, 23:2696.","journal-title":"Mol Basel Switz"},{"key":"ref64","doi-asserted-by":"crossref","DOI":"10.3390\/molecules15010432","article-title":"In vitro and in vivo effects of three different Mitragyna speciosa Korth leaf extracts on phase II Drug Metabolizing Enzymes\u2014Glutathione Transferases (GSTs).","volume":"15","author":"Azizi J","year":"2010","unstructured":"Azizi J, Ismail S, Mordi MN, Ramanathan S, Said MIM, Mansor SM. In vitro and in vivo effects of three different Mitragyna speciosa Korth leaf extracts on phase II Drug Metabolizing Enzymes\u2014Glutathione Transferases (GSTs)..  Molecules. 2010, 15:432-41.","journal-title":"Molecules"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1515\/dmdi-2012-0039","article-title":"Mitragyna speciosa Korth leaves extracts induced the CYP450 catalyzed aminopyrine-N-demethylase (APND) and UDP-glucuronosyl transferase (UGT) activities in male Sprague-Dawley rat livers","volume":"28","author":"Azizi J","year":"2013","unstructured":"Azizi J, Ismail S, Mansor SM. Mitragyna speciosa Korth leaves extracts induced the CYP450 catalyzed aminopyrine-N-demethylase (APND) and UDP-glucuronosyl transferase (UGT) activities in male Sprague-Dawley rat livers. Drug Metabol Drug Interact. 2013, 28:95-105. 10.1515\/dmdi-2012-0039","journal-title":"Drug Metabol Drug Interact"},{"key":"ref66","article-title":"A case report of kratom addiction and withdrawal","volume":"115","author":"Galbis-Reig D","year":"2016","unstructured":"Galbis-Reig D. A case report of kratom addiction and withdrawal. WMJ. 2016, 115:49-52.","journal-title":"WMJ"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29698","article-title":"A case of severe kratom addiction contributing to a suicide attempt","volume":"14","author":"Settle AG","year":"2022","unstructured":"Settle AG, Yang C. A case of severe kratom addiction contributing to a suicide attempt. Cureus. 2022, 14:e29698. 10.7759\/cureus.29698","journal-title":"Cureus"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2021.1878086","article-title":"Management of kratom dependence with buprenorphine\/naloxone in a veteran population","volume":"42","author":"Lei J","year":"2021","unstructured":"Lei J, Butz A, Valentino N. Management of kratom dependence with buprenorphine\/naloxone in a veteran population. Subst Abus. 2021, 42:497-502. 10.1080\/08897077.2021.1878086","journal-title":"Subst Abus"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.6588","article-title":"A case of kratom-induced seizures","volume":"12","author":"Afzal H","year":"2020","unstructured":"Afzal H, Esang M, Rahman S. A case of kratom-induced seizures. Cureus. 2020, 12:e6588. 10.7759\/cureus.6588","journal-title":"Cureus"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.764885","article-title":"Evaluation of kratom opioid derivatives as potential treatment option for alcohol use disorder","volume":"12","author":"Gutridge AM","year":"2021","unstructured":"Gutridge AM, Chakraborty S, Varga BR, et al.. Evaluation of kratom opioid derivatives as potential treatment option for alcohol use disorder. Front Pharmacol. 2021, 12:764885. 10.3389\/fphar.2021.764885","journal-title":"Front Pharmacol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2021.2010250","article-title":"Long-term buprenorphine treatment for kratom use disorder: a case series","volume":"43","author":"Broyan VR","year":"2022","unstructured":"Broyan VR, Brar JK, Allgaier Student T, Allgaier JT. Long-term buprenorphine treatment for kratom use disorder: a case series. Subst Abus. 2022, 43:763-6. 10.1080\/08897077.2021.2010250","journal-title":"Subst Abus"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000721","article-title":"Treatment of kratom withdrawal and dependence with buprenorphine\/naloxone: a case series and systematic literature review","volume":"15","author":"Weiss ST","year":"2021","unstructured":"Weiss ST, Douglas HE. Treatment of kratom withdrawal and dependence with buprenorphine\/naloxone: a case series and systematic literature review. J Addict Med. 2021, 15:167-72. 10.1097\/ADM.0000000000000721","journal-title":"J Addict Med"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.640218","article-title":"Case report: treatment of kratom use disorder with a classical tricyclic antidepressant","volume":"12","author":"Vento AE","year":"2021","unstructured":"Vento AE, de Persis S, De Filippis S, Schifano F, Napoletano F, Corkery JM, Kotzalidis GD. Case report: treatment of kratom use disorder with a classical tricyclic antidepressant. Front Psychiatry. 2021, 12:640218. 10.3389\/fpsyt.2021.640218","journal-title":"Front Psychiatry"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2019.1671945","article-title":"Home induction and outpatient treatment of kratom use disorder with buprenorphine-naloxone: a case report in a young adult","volume":"41","author":"Schmuhl KK","year":"2020","unstructured":"Schmuhl KK, Gardner SM, Cottrill CB, Bonny AE. Home induction and outpatient treatment of kratom use disorder with buprenorphine-naloxone: a case report in a young adult. Subst Abus. 2020, 41:311-4. 10.1080\/08897077.2019.1671945","journal-title":"Subst Abus"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.35756","article-title":"The Sigma Enigma: a narrative review of Sigma receptors","volume":"15","author":"Pergolizzi J","year":"2023","unstructured":"Pergolizzi J, Varrassi G, Coleman M, Breve F, Christo DK, Christo PJ, Moussa C. The Sigma Enigma: a narrative review of Sigma receptors. Cureus. 2023, 15:e35756. 10.7759\/cureus.35756","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/193602-kratom-a-narrative-review-of-the-possible-clinical-uses-and-dangers-of-this-opioid-like-plant","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T14:24:27Z","timestamp":1730816667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/193602-kratom-a-narrative-review-of-the-possible-clinical-uses-and-dangers-of-this-opioid-like-plant"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":75,"URL":"https:\/\/doi.org\/10.7759\/cureus.73058","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,5]]}}}